Editorial

View All
Your Trusted Source for Biopharma News
Editorial From Breakthroughs to Scale: Biopharma Platforms Shaping 2026

In 2026, boards and customers are asking a direct question: can promising science be turned into reliable, affordable systems that deliver audited outcomes at scale, quarter after quarter, without…

Biopharma's 2026 Playbook: AI, M&A, and the Race for Pipeline Security
EditorialBiopharma's 2026 Playbook: AI, M&A, and the Race for Pipeline Security

The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions

Seven Biopharma Trends to Watch in 2026
EditorialSeven Biopharma Trends to Watch in 2026

The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at

How Will the Global Obesity Market Accelerate Through 2026?
EditorialHow Will the Global Obesity Market Accelerate Through 2026?

The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as

The CMC Challenge of Scaling Cell and Gene Therapies
EditorialThe CMC Challenge of Scaling Cell and Gene Therapies

Advanced Therapy Medicinal Products cannot be scaled the same way biologics were. The core

View All

Research & Development

View All
View All

Tech & Innovation

View All
View All
Can Biomarkers End Trial and Error in Depression Treatment?
Tech & Innovation Can Biomarkers End Trial and Error in Depression Treatment?

Standard clinical practice often requires patients to wait months to determine if a Selective Serotonin Reuptake Inhibitor is effective, leading to significant emotional and financial burdens. This trial-and-error approach remains the dominant method for addressing Major Depressive Disorder, a

Validation Accords and the Future of Clinical AI Regulation
Tech & InnovationValidation Accords and the Future of Clinical AI Regulation

As AI-generated outputs like safety narrative summaries become part of the official evidentiary

Can AI-Designed Rentosertib Revolutionize Lung Disease Care?
Tech & InnovationCan AI-Designed Rentosertib Revolutionize Lung Disease Care?

The pharmaceutical industry is experiencing a defining transformation as the first patient recently

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later